Short Interest in Siemens Healthineers AG (OTCMKTS:SMMNY) Increases By 485.4%

Siemens Healthineers AG (OTCMKTS:SMMNY) was the target of a significant increase in short interest in the month of June. As of June 15th, there was short interest totaling 116,151 shares, an increase of 485.4% from the May 31st total of 19,840 shares. Based on an average daily trading volume, of 284,099 shares, the short-interest ratio is currently 0.4 days.

Siemens Healthineers Stock Performance

OTCMKTS SMMNY traded down $0.10 on Friday, reaching $19.43. The company’s stock had a trading volume of 241,836 shares, compared to its average volume of 169,194. Siemens Healthineers has a 52 week low of $19.32 and a 52 week high of $28.92. The business has a 50-day moving average price of $20.29 and a 200 day moving average price of $22.91.

Siemens Healthineers (OTCMKTS:SMMNY) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.02. The business had revenue of $6.68 billion for the quarter, compared to the consensus estimate of $6.96 billion.

Analyst Upgrades and Downgrades

Separately, Zacks Research lowered Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research note on Friday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy”.

About Siemens Healthineers

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.